Efficacy and safety of dalbavancin as suppressive therapy in chronic implant-associated infections
- DOI
- 10.1016/j.idnow.2026.105268
- Published
- 2026-05
- Container
- Infectious Diseases Now
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.idnow.2026.105268,
title = {Efficacy and safety of dalbavancin as suppressive therapy in chronic implant-associated infections},
author = {Tomaso Beringheli and Céline Dupieux and Sylvain Goutelle and Tiphaine Roussel-Gaillard and Carole Dhelens and Pauline Rascle and Charlotte Doudet and Sandrine Roux and Clément Javaux and Claire Triffault-Fillit and Evelyne Braun and Tristan Ferry and Florent Valour},
year = {2026},
journal = {Infectious Diseases Now},
doi = {10.1016/j.idnow.2026.105268},
url = {https://doi.org/10.1016/j.idnow.2026.105268}
}RIS
TY - JOUR TI - Efficacy and safety of dalbavancin as suppressive therapy in chronic implant-associated infections AU - Tomaso Beringheli AU - Céline Dupieux AU - Sylvain Goutelle AU - Tiphaine Roussel-Gaillard AU - Carole Dhelens AU - Pauline Rascle AU - Charlotte Doudet AU - Sandrine Roux AU - Clément Javaux AU - Claire Triffault-Fillit AU - Evelyne Braun AU - Tristan Ferry AU - Florent Valour PY - 2026 JO - Infectious Diseases Now DO - 10.1016/j.idnow.2026.105268 UR - https://doi.org/10.1016/j.idnow.2026.105268 ER -
APA
Beringheli, T., Dupieux, C., Goutelle, S., Roussel-Gaillard, T., Dhelens, C., Rascle, P., Doudet, C., Roux, S., Javaux, C., Triffault-Fillit, C., Braun, E., Ferry, T., & Valour, F. (2026). Efficacy and safety of dalbavancin as suppressive therapy in chronic implant-associated infections. Infectious Diseases Now. https://doi.org/10.1016/j.idnow.2026.105268
Source records
- crossref · retrieved 2026-09-26T19:14:14.373Z